Free Trial

Joshua Jennings Analyst Performance

Analyst at TD Cowen

Joshua Jennings is a stock analyst at TD Cowen, covering 2 publicly traded companies across a range of sectors. Over the past year, Joshua Jennings has issued 2 stock ratings, including and buy recommendations. While full access to Joshua Jennings' proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Joshua Jennings' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
2 Last 0 Years
Buy Recommendations
100.00% 2 Buy Ratings
Companies Covered
2 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%2 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
50.0% of companies on NASDAQ
1 company
NYSE
50.0% of companies on NYSE
1 company

Joshua Jennings, an analyst at TD Cowen, currently covers 2 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
2 companies
100.0%

Joshua Jennings of TD Cowen specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
1 company
50.0%
PROCESS CONTROL INSTRUMENTS
1 company
50.0%

Joshua Jennings' Ratings History at TD Cowen

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Humacyte, Inc. stock logo
HUMA
Humacyte
8/12/2025Lower Price Target$1.89$3.50Buy
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
7/15/2025Initiated Coverage$0.51$1.25Buy